Oliver Pfaar

23.4k total citations · 1 hit paper
265 papers, 5.2k citations indexed

About

Oliver Pfaar is a scholar working on Immunology and Allergy, Physiology and Dermatology. According to data from OpenAlex, Oliver Pfaar has authored 265 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 229 papers in Immunology and Allergy, 170 papers in Physiology and 125 papers in Dermatology. Recurrent topics in Oliver Pfaar's work include Allergic Rhinitis and Sensitization (224 papers), Asthma and respiratory diseases (169 papers) and Dermatology and Skin Diseases (101 papers). Oliver Pfaar is often cited by papers focused on Allergic Rhinitis and Sensitization (224 papers), Asthma and respiratory diseases (169 papers) and Dermatology and Skin Diseases (101 papers). Oliver Pfaar collaborates with scholars based in Germany, United States and United Kingdom. Oliver Pfaar's co-authors include Ludger Klimek, Moisés A. Calderón, Pascal Demoly, Ralph Mösges, Karl Hörmann, Jean Bousquet, Stephen R. Durham, Roy Gerth van Wijk, Jörg Kleine‐Tebbe and Karl‐Christian Bergmann and has published in prestigious journals such as New England Journal of Medicine, Journal of Allergy and Clinical Immunology and BioMed Research International.

In The Last Decade

Oliver Pfaar

243 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps

2025 35 citations Oliver Pfaar et al. profile →

Peers

Countries citing papers authored by Oliver Pfaar

Since Specialization

Citations

This map shows the geographic impact of Oliver Pfaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Pfaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Pfaar more than expected).

Fields of papers citing papers by Oliver Pfaar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Pfaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Pfaar. The network helps show where Oliver Pfaar may publish in the future.

Co-authorship network of co-authors of Oliver Pfaar

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Pfaar. A scholar is included among the top collaborators of Oliver Pfaar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Pfaar. Oliver Pfaar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Quality of life in type 2 and non‐type 2 endotypes in chronic rhinosinusitis with nasal polyps: A prospective trial 2025 ·Clinical and Translational Allergy ·(unknown), (unknown), Stefan Dazert, Stefan Volkenstein, (unknown), (unknown), Oliver Pfaar	1
2	The Minimal Clinically Important Difference in Allergen Immunotherapy: An Evidence‐Based Approach 2025 ·Allergy ·Oliver Pfaar, Ralph Mösges, Michael S. Blaiss, Sven Becker, L. DuBuske, Jonathan A. Bernstein, Uwe Berger, (unknown), Stephanie Dramburg, Mohamed H. Shamji, (unknown), (unknown), Katrin Birkholz, (unknown), (unknown), Matthias Krämer, Murray Skinner, Pieter‐Jan de Kam	0
3	Chronic rhinosinusitis with nasal polyps: Key considerations in the multidisciplinary team approach 2025 ·Clinical and Translational Allergy ·Oliver Pfaar, Anju T. Peters, Camille Taillé, (unknown), Jared Silver, Robert Chan, Peter W. Hellings	3
4	Improved quality control of allergen products: Assessing the molecular allergen composition by mass spectrometry 2024 ·Allergy ·Steffen Augustin, Thomas Eichhorn, Martin Wald, Frank Fischer, Marek Jutel, Oliver Pfaar, Christoph Willers	2
5	Comparison of two different pollen season definitions based on 10 years of birch and grass pollen data from two distant central European cities: An EAACI Task Force report 2024 ·Allergy ·Oliver Pfaar, Maximilian Bastl, (unknown), Uwe Berger, Kostas Karatzas, (unknown), Barbora Werchan, Matthias Werchan, Karl‐Christian Bergmann	1
6	Treatment with the SQ tree sublingual immunotherapy tablet is safe and well tolerated in real‐life 2024 ·Clinical and Translational Allergy ·Oliver Pfaar, Hendrik Wolf, (unknown), André C. Knulst, K Sidenius, (unknown), Sverre Steinsvåg, Christer Janson, L. van der Zwan, (unknown), Peter Arvidsson, (unknown), (unknown), Eike Wüstenberg	2
7	Short‐course subcutaneous treatment with birch pollen allergoids greatly improves symptom and medication scores in birch allergy 2024 ·Allergy ·Ralph Mösges, E Raskopf, Ludger Klimek, Oliver Pfaar, Stefan Zielen, (unknown), (unknown), (unknown), (unknown), Cengizhan Açıkel, Hacer Sahin, (unknown), (unknown), José Luis Subiza, Miguel Casanovas, Mandy Cuevas	4
8	Current advances in house dust mite allergen immunotherapy (AIT): Routes of administration, biomarkers and molecular allergen profiling 2023 ·Molecular Immunology ·Thierry Batard, Giorgio Walter Canonica, Oliver Pfaar, Mohamed H. Shamji, Robyn E. O’Hehir, Menno C. van Zelm, Laurent Mascarell	6
9	Adherence and persistence in allergen immunotherapy (APAIT): A reporting checklist for retrospective studies 2023 ·Allergy ·Oliver Pfaar, Philippe Devillier, Jochen Schmitt, Pascal Demoly, Ole Hilberg, L. DuBuske, Nicole Hass, Ted Klok, (unknown)	4
10	Eosinophilic esophagitis as a side-effect of allergen immunotherapy: protocol for a systematic review and meta-analysis 2023 ·European Annals of Allergy and Clinical Immunology ·Constantinos Pitsios, Carlo Maria Rossi, Ingrid Terreehorst, Enrico Heffler, Martina Votto, George Ν. Konstantinou, Alberto Álvarez‐Perea, Arzu Bakırtaş, (unknown), Darío Antolín‐Amérigo, Georgios K. Nikolopoulos, Oliver Pfaar, Antonella Cianferoni	5
11	Allergic patients during the COVID‐19 pandemic—Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey 2022 ·Clinical and Translational Allergy ·Montserrat Álvaro‐Lozano, (unknown), Mattia Giovannini, Erika Jensen‐Jarolim, Ümit Murat Şahiner, Vesna Tomić-Spirić, (unknown), Adam Chaker, Enrico Heffler, Ludger Klimek, Helen A. Brough, Gunter J. Sturm, Eva Untersmayr, (unknown), Oliver Pfaar	10
12	Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19 2022 ·Allergy ·Milena Sokołowska, G. Enrico Rovati, Zuzana Diamant, Eva Untersmayr, Jürgen Schwarze, Zuzanna Łukasik, (unknown), Alba Angelina, Óscar Palomares, Cezmi A. Akdiş, Liam O’Mahony, Miloš Jeseňák, Oliver Pfaar, Marı́a José Torres, Marek Sanak, Sven‐Erik Dahlén, Grzegorz Woszczek	13
13	ARIA (Allergic Rhinitis and its Impact on Asthma) 2019. Percorsi di cura per la rinite allergica – ITALIA 2021 ·Recenti Progressi in Medicina ·Giovanni Passalacqua, Lorenzo Cecchi, Giorgio Walter Canonica, Carlo Lombardi, Maria Teresa Ventura, Claus Bachert, (unknown), Tari Haahtela, Ludger Klimek, Nikolaos G. Papadopoulos, Oliver Pfaar, Arūnas Valiulis, Gabrielle L. Onorato, (unknown), Anna Bedbrook, Jean Bousquet	1
14	The need for Pan‐European automatic pollen and fungal spore monitoring: A stakeholder workshop position paper 2021 ·Clinical and Translational Allergy ·Fiona Tummon, Lucas Alados‐Arboledas, Maira Bonini, Benjamin Guinot, (unknown), Christophe Jacob, Vladimir Kendrovski, (unknown), Eric Petermann, Vincent‐Henri Peuch, Oliver Pfaar, Michaël Sicard, Branko Šikoparija, Bernard Clot	20
15	Noninvasive and minimally invasive techniques for the diagnosis and management of allergic diseases 2020 ·Allergy ·Ralf Baumann, Eva Untersmayr, Ulrich M. Zissler, Stefanie Eyerich, Ian M. Adcock, Knut Brockow, Tilo Biedermann, Markus Ollert, Adam Chaker, Oliver Pfaar, Holger Garn, Ryan S. Thwaites, Alkis Togias, Marek L. Kowalski, Trevor T. Hansel, Constanze A. Jakwerth, Carsten B. Schmidt‐Weber	23
16	State‐of‐the‐art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI) 2019 ·Allergy ·Erika Jensen‐Jarolim, Martin F. Bachmann, С. Бонини, Lars Jacobsen, Marek Jutel, Ludger Klimek, Vera Mahler, Ralph Mösges, Philippe Moingeon, (unknown), Óscar Palomares, Oliver Pfaar, Harald Renz, Claudio Rhyner, Franziska Roth‐Walter, Michael Rudenko, J. Savolainen, Carsten B. Schmidt‐Weber, Claudia Traidl‐Hoffmann, Thomas M. Kündig	49
17	Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double‐blind, placebo‐controlled trial 2018 ·Allergy ·Ralph Mösges, Claus Bachert, Petr Panzner, Moisés A. Calderón, (unknown), Sabine Pirotton, (unknown), Stephen R. Durham, (unknown), (unknown), R. von Frenckell, Oliver Pfaar, Mohamed H. Shamji	38
18	Sublingual grass and ragweed immunotherapy: Clinical considerations—a PRACTALL consensus report 2015 ·Journal of Allergy and Clinical Immunology ·James T. Li, David I. Bernstein, Moisés A. Calderón, Thomas B. Casale, Linda Cox, Giovanni Passalacqua, Oliver Pfaar, Nikolaos G. Papadopoulos	31
19	Depigmented–polymerized mixed grass/birch pollen extract immunotherapy is effective in polysensitized patients 2013 ·Allergy ·Oliver Pfaar, Tilo Biedermann, Ludger Klimek, (unknown), Douglas S. Robinson	30
20	Skin tests for diagnostics of allergic immediate-type reactions 2011 ·mediaTUM (Technical University of Munich) ·(unknown), Karl‐Christian Bergmann, Knut Brockow, Thomas Fuchs, A. Grübl, Kyung Eun Jung, Ludger Klimek, H. Müsken, Oliver Pfaar, Bernhard Przybilla, H. Sitter, Wolfgang Wehrmann	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact